Katarina Laurell1, Ville Artto2, Lars Bendtsen3, Knut Hagen4, Johan Häggström5, Mattias Linde4, Lars Söderström6, Erling Tronvik7, Maija Wessman8, John Anker Zwart9, Mikko Kallela2. 1. Department of Pharmacology and Clinical Neuroscience, Umeå University, Sweden Katarina.Laurell@neuro.umu.se. 2. Department of Neurology, Helsinki University Central Hospital, Finland. 3. Department of Neurology, Danish Headache Centre, Glostrup Hospital, Denmark University of Copenhagen, Denmark. 4. Norwegian National Headache Centre, Trondheim University Hospital, Norway Department of Neurosciences, Norwegian University of Science and Technology, Trondheim, Norway. 5. Department of Pharmacology and Clinical Neuroscience, Umeå University, Sweden. 6. Unit of Research, Education and Development, Östersund Hospital, Region Jämtland Härjedalen, Sweden. 7. Norwegian National Headache Centre, Trondheim University Hospital, Norway Department of Neurosciences, Norwegian University of Science and Technology, Trondheim, Norway Department of Neurology, Trondheim University Hospital, Norway. 8. Institute of Genetics, Folkhälsan Research Center, Finland Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Finland. 9. Department of Neurology and FORMI, Oslo University Hospital and University of Oslo, Norway.
Authors: Ana B Gago-Veiga; Josué Pagán; Kevin Henares; Patricia Heredia; Nuria González-García; María-Irene De Orbe; Jose L Ayala; Mónica Sobrado; Jose Vivancos Journal: J Pain Res Date: 2018-09-27 Impact factor: 3.133